文献速递前列腺癌

SPINK1表达在非裔美国男性前列腺癌中富集,但与前列腺切除术后免疫浸润改变或肿瘤学结局无关

SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2019-03-08

研究纳入186例非裔美国(AA)和206例欧洲美国(EA)接受根治性前列腺切除术的前列腺癌男性,按病理分级匹配,用组织微阵列免疫组化检测SPINK1状态。SPINK1阳性亚型在AA男性中占25%(45/186),高于EA男性的15%(30/206)(p=0.013)。在总体队列或按种族分层中,SPINK1阳性与阴性肿瘤在病理分级、病理分期、无生化复发生存或无转移生存方面均无差异;多因素分析中SPINK1表达与生化复发或转移均无关。

要点

  • SPINK1阳性亚型在AA男性中占25%(45/186),EA男性中占15%(30/206),差异有统计学意义(p=0.013)。
  • 总体队列或按种族分层,SPINK1阳性与阴性肿瘤的病理分级、病理分期、无生化复发生存、无转移生存均无差异。
  • 多因素分析中SPINK1表达与生化复发和转移均无关,AA与EA男性中均无显著关联。

核心结论

  • SPINK1阳性亚型在AA前列腺癌男性中比EA男性更常见。
  • 与既往研究相反,SPINK1蛋白表达与AA或EA男性根治性前列腺切除术后更差的病理或肿瘤学结局无关。

研究设计与样本

  • 共纳入186例AA和206例EA接受根治性前列腺切除术的男性,按病理分级匹配。
  • 用经遗传学验证的检测方法在组织微阵列上通过免疫组化检查SPINK1状态。
  • 用Cox比例风险分析在种族特异性多因素模型中评估SPINK1状态与肿瘤学结局的关联。
  • 第二个目标是用免疫染色和自动图像分析确定CD3/CD8 T细胞密度与SPINK1状态及种族的相关性。

主要发现

  • SPINK1阳性亚型在AA男性中占25%(45/186),在EA男性中占15%(30/206)(p=0.013)。
  • 总体队列或按种族分层,SPINK1阳性与阴性肿瘤在病理分级、病理分期、无生化复发生存或无转移生存方面均无差异。
  • 多因素分析中SPINK1表达与生化复发无关(AA:HR 0.99,95%CI 0.56-1.75,p=0.976;EA:HR 0.88,95%CI 0.43-1.77,p=0.720)。
  • 多因素分析中SPINK1表达与转移无关(AA:HR 0.79,95%CI 0.25-2.49,p=0.691;EA:HR 1.55,95%CI 0.58-4.11,p=0.381)。
  • 两种种族中SPINK1阳性与阴性肿瘤周围CD3/CD8淋巴细胞密度均无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The SPINK1 molecular subtype is more common in African-American (AA) men with prostatic adenocarcinoma (PCa) than European Americans (EA). Studies have suggested that SPINK1 expression is associated with more aggressive disease. However, the size, follow-up, and racial diversity of prior patient cohorts have limited our understanding of SPINK1 expression in AA men. The objective was to determine the associations between SPINK1 subtype, race, and oncologic outcomes after radical prostatectomy (RP). METHODS: A total of 186 AA and 206 EA men who underwent RP were matched according to pathologic grade. We examined SPINK1 status by immunohistochemistry on tissue microarrays using a genetically validated assay. Cox proportional hazard analyses assessed the association of SPINK1 status with oncologic outcomes in race-specific multivariate models. A second objective was to determine the correlation between CD3/CD8 T cell densities with SPINK1 status and race, using immunostaining and automated image analysis. RESULTS: SPINK1-positive subtype was present in 25% (45/186) of AA and 15% (30/206) of EA men (p = 0.013). There were no differences in pathologic grade, pathologic stage, biochemical recurrence (BCR)-free survival, or metastasis-free survival between SPINK1-positive and SPINK1-negative tumors in the overall cohort or by race. In multivariate analyses, SPINK1 expression was not associated with BCR (AA: HR 0.99, 95% CI 0.56-1.75, p = 0.976; EA: HR 0.88, 95% CI 0.43-1.77, p = 0.720) or metastasis (AA: HR 0.79, 95% CI 0.25-2.49, p = 0.691; EA: HR 1.55, 95% CI 0.58-4.11, p = 0.381) in either AA or EA men. There were no significant differences in surrounding CD3/CD8 lymphocyte densities between SPINK1-positive and SPINK1-negative tumors in either race. CONCLUSIONS: SPINK1-positive subtype is more prevalent in AA than EA men with PCa. Contrary to previous studies, we found that SPINK1 protein expression was not associated with worse pathologic or oncologic outcomes after RP in either AA men or EA men.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Faisal FA, Kaur HB, Tosoian JJ, et al. SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy. Prostate Cancer Prostatic Dis. 2019. PMID: 30850708. doi:10.1038/s41391-019-0139-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。